Core Viewpoint - The recent death of a young female tourist in Sanya due to a suspected snake bite has raised concerns about the availability and adequacy of antivenom supply in hospitals, particularly in regions with high incidences of snake bites [1][2][4]. Antivenom Production and Availability - Currently, there is only one company, Sairun Biotech, that produces antivenom in China, with only four types available: for pit vipers, cobras, five-step snakes, and banded krait [6][7]. - In 2024, Sairun Biotech reported a revenue of 158 million yuan from antivenom sales, a slight increase of 1.17% year-on-year, with a production volume of 172,900 vials, up 46.68% from the previous year [7]. Treatment Protocols and Challenges - The treatment of snake bites is highly dependent on the experience of medical professionals, emphasizing the need for timely administration of antivenom based on clinical symptoms rather than waiting for definitive identification of the snake species [3][4]. - The guidelines recommend early and adequate use of antivenom, which is crucial for improving patient outcomes [5][4]. Regional Variations in Antivenom Storage - Hospitals in regions with high snake bite incidents, such as Xiangtan, Guangzhou, and Lishui, maintain stocks of the four types of antivenom based on local snake species prevalence [8][9]. - Some hospitals may not stock antivenom due to high costs, short shelf life, and the financial burden of expired products [10][9]. Public Health Implications - Snake bites are a significant public health issue in China, with an estimated 250,000 to 280,000 cases annually, predominantly affecting individuals over 50 years old [4]. - The lack of awareness and access to proper treatment can lead to severe complications and fatalities, highlighting the need for better public health education and resources [13][12]. Future Developments - There is potential for market growth in antivenom production, as current offerings do not cover all snake species, and additional companies are exploring the development of new antivenoms [13][15]. - Sairun Biotech is currently conducting clinical research on antivenom for viper bites, which could expand treatment options in the future [15][16].

6月5日，家属向《齐鲁晚报》记者表示，他们要求调取录像，双方已进行两次沟通，内容暂不便透露， 相关医生已被停职。 据家属此前回应，三亚市卫健委牵头召开会议，承诺5天内给出调查结果，会确认咬人的是不是毒蛇、 是什么毒蛇。《齐鲁晚报》则于今日获悉，海南省卫健委已经介入。 "是不是蛇咬伤？""医生判断蛇毒究竟有多难？"有没有'解药'？"在该事件的讨论中，公众最关心的莫过 于这一系列"保命"问题。 连日来，一名游客被不明物咬伤后身亡的消息，引发社会广泛讨论。 据三亚市卫健委6月3日通报，一名游客于6月2日凌晨零时许，在步行回酒店途中被不明物咬伤并流血。 回酒店简单消毒并处理伤口后，患者坐出租车于1:05到达三亚某医院。 医院体格检查显示，右第2趾可见一浅表咬伤。初步诊断为足部虫咬伤、不明物咬伤。第二次查血结果 出来后，医生称不排除是毒蛇咬伤，医院没有相关救治经验，建议转院。 多名专家表示，若是毒蛇咬伤，属于可治愈的疾病，现有抗蛇毒血清治疗效果明确，能避免大部分死 亡、严重后果。 "但救治的关键有一半在于伤者和家属，如果伤者就医较晚、中毒量太大，已经发生器质性变化甚至脏 器衰竭，损伤可能是不可逆的。"广州医科大学附属第 ...